. 2012 Apr 30;12(4):253–258. doi: 10.5812/hepatmon.665

Table 2. Prevalence of HBV Serological Markers as Well as HBV DNA in the Study Population ^a.

	All Patients (n = 145)	Group 1 (n = 79)	Group 2 (n = 66)	P value
Anti-HBc ^b IgG seropositivity	29 (20)	20 (25.3)	9 (13.6)	0.03
Anti-HBs and anti-HBc IgG seropositivity	15 (10.34)	10 (12.6)	5 (7.5)	0.4
Anti-HBc (+), anti-HBe	14 (9.6)	10 (12.6)	4 (6.06)	0.5
HBV DNA ^c positivity	6 (4.1)	4 (5.06)	2 (3.03)	0.2

^a Data are Shown as No. (%).

^b Abbreviations: Anti-HBc, hepatitis B core antibody

^c HBV DNA, hepatitis B virus DNA by polymerase chain reaction

Table 2. Prevalence of HBV Serological Markers as Well as HBV DNA in the Study Population a.